Form 8-K - Current report:
SEC Accession No. 0001558370-23-006434
Filing Date
2023-04-21
Accepted
2023-04-21 16:00:13
Documents
14
Period of Report
2023-04-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K glyc-20230419x8k.htm   iXBRL 8-K 43616
2 EX-10.1 glyc-20230419xex10d1.htm EX-10.1 49882
3 GRAPHIC glyc-20230419xex10d1002.jpg GRAPHIC 2339
  Complete submission text file 0001558370-23-006434.txt   222275

Data Files

Seq Description Document Type Size
4 EX-101.SCH glyc-20230419.xsd EX-101.SCH 3375
5 EX-101.LAB glyc-20230419_lab.xml EX-101.LAB 15361
6 EX-101.PRE glyc-20230419_pre.xml EX-101.PRE 10380
8 EXTRACTED XBRL INSTANCE DOCUMENT glyc-20230419x8k_htm.xml XML 4658
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36177 | Film No.: 23836239
SIC: 2834 Pharmaceutical Preparations